Genmab Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,901	3,720	3,121	2,390	2,084	1,287
Revenue Growth (YoY)	20.66%	19.19%	30.59%	14.68%	61.88%	-22.52%
Cost of Revenue	261	238	143	33	-	-
Gross Profit	3,640	3,482	2,978	2,357	2,084	1,287
Selling, General & Admin	666	626	549	478	384.48	196.24
Research & Development	1,687	1,606	1,414	1,107	799.14	639.51
Operating Expenses	2,353	2,232	1,963	1,585	1,184	835.75
Operating Income	1,287	1,250	1,015	772	900.43	451.68
Interest Expense	-168	-61	-18	-10	-5.6	-1.99
Interest & Investment Income	119	138	144	142	46.55	30.13
Currency Exchange Gain (Loss)	-22	-3	92	-66	151.01	224.85
EBT Excluding Unusual Items	1,216	1,324	1,233	838	1,092	704.67
Merger & Restructuring Charges	-230	-185	-43	-	-	-
Gain (Loss) on Sale of Investments	48	65	136	-21	-94.54	-105.39
Pretax Income	1,034	1,204	1,326	817	997.85	599.28
Income Tax Expense	213	241	193	186	214.51	146.99
Net Income	821	963	1,133	631	783.33	452.29
Net Income to Common	821	963	1,133	631	783.33	452.29
Net Income Growth	-27.73%	-15.00%	79.56%	-19.45%	73.19%	-42.16%
Shares Outstanding (Basic)	62	62	64	65	65	65
Shares Outstanding (Diluted)	63	63	65	66	66	66
Shares Change (YoY)	-2.55%	-3.04%	-1.88%	-0.17%	-0.06%	0.24%
EPS (Basic)	13.24	15.49	17.65	9.66	11.98	6.92
EPS (Diluted)	13.11	15.37	17.53	9.58	11.87	6.85
EPS Growth	-25.81%	-12.32%	82.98%	-19.27%	73.29%	-42.30%
Free Cash Flow	872	1,149	1,099	1,018	516.52	302.24
Free Cash Flow Per Share	13.91	18.33	17.00	15.45	7.83	4.58
Gross Margin	93.31%	93.60%	95.42%	98.62%	100.00%	100.00%
Operating Margin	32.99%	33.60%	32.52%	32.30%	43.21%	35.08%
Profit Margin	21.05%	25.89%	36.30%	26.40%	37.59%	35.13%
Free Cash Flow Margin	22.35%	30.89%	35.21%	42.59%	24.79%	23.48%
EBITDA	1,330	1,290	1,052	802	941.81	481.35
EBITDA Margin	34.09%	34.68%	33.71%	33.56%	45.19%	37.39%
D&A For EBITDA	43	40	37	30	41.38	29.67
EBIT	1,287	1,250	1,015	772	900.43	451.68
EBIT Margin	32.99%	33.60%	32.52%	32.30%	43.21%	35.08%
Effective Tax Rate	20.60%	20.02%	14.56%	22.77%	21.50%	24.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.